首页> Research and practice in thrombosis and haemostasis> Safety and effectiveness of apixaban compared to warfarin in dialysis patients.

Safety and effectiveness of apixaban compared to warfarin in dialysis patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Daniel,Reed

第一单位： Division of Hematology & Oncology University of Virginia Charlottesville VA USA.

作者： Daniel,Reed ^[1] ; Surabhi,Palkimas ^[2] ; Rebecca,Hockman ^[2] ; Sumner,Abraham ^[3] ; Tri,Le ^[1] ; Hillary,Maitland ^[1]

作者单位： Division of Hematology & Oncology University of Virginia Charlottesville VA USA. ^[1] Department of Pharmacy University of Virginia Charlottesville VA USA. ^[2] Department of Medicine University of Virginia Charlottesville VA USA. ^[3]

关键词 anticoagulation apixaban dialysis hemorrhage venous thromboembolism warfarin

DOI 10.1002/rth2.12083

PMID 30046731

发布时间 2023-09-26

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Research and practice in thrombosis and haemostasis

2018年2卷2期

291-298页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Research and practice in thrombosis and haemostasis

2018年2卷2期

291-298页

检索历史清除

Safety and effectiveness of apixaban compared to warfarin in dialysis patients.

Research and practice in thrombosis and haemostasis

相似文献

同项目论文

Research and practice in thrombosis and haemostasis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Safety and effectiveness of apixaban compared to warfarin in dialysis patients.

Research and practice in thrombosis and haemostasis

相似文献

同项目论文

Research and practice in thrombosis and haemostasis

相关期刊

检索历史清除